<DOC>
	<DOCNO>NCT01730534</DOCNO>
	<brief_summary>This study carry determine effect dapagliflozin cardiovacular outcomes add current background therapy patient type 2 diabetes either establish cardiovacular disease cardiovascular risk factor .</brief_summary>
	<brief_title>Multicenter Trial Evaluate Effect Dapagliflozin Incidence Cardiovascular Events</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Provision inform consent prior study specific procedure Female male age â‰¥40 year Diagnosed Type 2 Diabetes High Risk Cardiovascular event Diagnosis Type 1 diabetes mellitus History bladder cancer history radiation therapy low abdomen pelvis time Chronic cystitis and/or recurrent urinary tract infection Pregnant breastfeeding patient</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>130 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Phase IIIb</keyword>
	<keyword>T2DM</keyword>
	<keyword>cardiovascular event</keyword>
</DOC>